# A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

> **NCT00501696** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 80 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** 4.5 mg Naltrexone
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT00501696
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2008-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501696, "A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00501696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*